Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals - Image 1

£98.76

CRC Press Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals

Name: Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals
Brand: CRC Press
Price: 98.76 GBP
Availability: InStock

Allied Health Professions

It has never been this cheap. We have no record of a lower price.

£99 today · cheaper than every other day in the last 24 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 617 days • 617 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 617 days • 5 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £135-144 (510 days, 82.7%)

Price range: £99 - £144

Price levels: 5 price ranges over 617 days

Description

Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals provides scientists responsible for the translation of novel biopharmaceuticals into clinical trials with a better understanding of how to navigate the obstacles that keep innovative medical research discoveries from becoming new therapies or even making it to clinical trials. The book includes sections on protein-based therapeutics, modified proteins, oligonucleotide-based therapies, monoclonal antibodies, antibody–drug conjugates, gene and cell-based therapies, gene-modified cell-based therapies, combination products, and therapeutic vaccines. Best practices are defined for efficient discovery research to facilitate a science-based, efficient, and predictive preclinical development program to ensure clinical efficacy and safety. Key Features: Defines best practices for leveraging of discovery research to facilitate a development program Includes general principles, animal models, biomarkers, preclinical toxicology testing paradigms, and practical applications Discusses rare diseases Discusses "What-Why-When-How" highlighting different considerations based upon product attributes. Includes special considerations for rare diseases About the Editors Joy A. Cavagnaro is an internationally recognized expert in preclinical development and regulatory strategy with an emphasis on genetic medicines.. Her 40-year career spans academia, government (FDA), and the CRO and biotech industries. She was awarded the 2019 Arnold J Lehman Award from the Society of Toxicology for introducing the concept of science-based, case-by-case approach to preclinical safety evaluation, which became the foundation of ICH S6. She currently serves on scientific advisory boards for advocacy groups and companies and consults and lectures in the area of preclinical development of novel therapies. Mary Ellen Cosenza is a regulatory toxicology consultant with over 30 years of senior leadership experience in the biopharmaceutical industry in the U.S., Europe, and emerging markets. She has held leadership position in both the American College of Toxicology (ACT) and the International Union of Toxicology (IUTOX) and is also an adjunct assistant professor at the University of Southern California where she teaches graduate-level courses in toxicology and regulation of biologics.

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 0367644274
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions
Domain: Amazon UK
Release Date: 26 November 2021
Listed Since: 14 May 2021

Barcode

No barcode data available

CRC Press Translational Medicine: Optimizing Preclinical Safety Evaluation of Biopharmaceuticals

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Toxicological Aspects of Medical Device Implants

A Comprehensive Guide to Toxicology in Nonclinical Drug Development

Lu's Basic Toxicology: Fundamentals, Target Organs, and Risk Assessment, Sixth Edition

Encyclopedia of Drug Metabolism and Interactions, 6 Volume Set

Practical Toxicology: Evaluation, Prediction, and Risk, Third Edition

Current Topics in Nonclinical Drug Development: Volume 2

In Vitro Toxicology Systems (Methods in Pharmacology and Toxicology)

High-Throughput Screening Methods in Toxicity Testing

Cellular and Molecular Toxicology: 14 (Comprehensive Toxicology): Volume 14

The Toxicologist's Pocket Handbook

Advances in Molecular Toxicology: Volume 9

Computational Systems Toxicology (Methods in Pharmacology and Toxicology)

Introduction to Toxicological Screening Methods and Good Laboratory Practice

Predictive Toxicology in Drug Safety

Regulatory Toxicology in the European Union: Volume 36 (Issues in Toxicology)

Casarett & Doull's Toxicology: The Basic Science of Poisons, Ninth Edition (PHARMACOLOGY)

A Comprehensive Guide to Toxicology in Nonclinical Drug Development

The Toxicologist's Pocket Handbook

Brainstorming Questions in Toxicology

Introduction to Toxicology

The Timing of Toxicological Studies to Support Clinical Trials (CMR Workshop)

Statistics in Toxicology Using R (Chapman & Hall/CRC The R Series)

Validation of Alternative Methods for Toxicity Testing: 856 (Advances in Experimental Medicine and Biology, 856)

Biomedical Product and Materials Evaluation: Standards and Ethics (Woodhead Publishing Series in Biomaterials)